Delivery Order SPE2DR25D3301-SPE2DR26F20TH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a contract ceiling value of $15,399.64. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The contract has an ultimate completion date of January 6, 2026, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $14,532.25. This firm fixed-price delivery order, which carries an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $3,275.55 and an ultimate completion date of October 20, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,097.78 for Ondansetron ODT 4 mg tablets (30-count supply) on November 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by December 1, 2025, and work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,754.83 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $1,081.27. This is a firm fixed-price contract with an ultimate completion date of January 14, 2026, and represents a competitively awarded, non-set-aside procurement. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in quantities of 30 tablets. This is a firm fixed-price delivery order with a ceiling value of $21,062.11 and an ultimate completion date of December 23, 2025. The contract utilizes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.71 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Ondansetron is a widely used anti-nausea medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,010.84 and an ultimate completion date of November 19, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $2,447.59. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set for ultimate completion by January 7, 2026, and performance will be executed from the contractor's location in Conshohocken,...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20THDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $2,173.14 and a firm fixed-price structure. This delivery order was issued without a set-aside designation, indicating full and open competition. The contract is scheduled for ultimate completion on January 15, 2026, with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the contractor to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems. Ondansetron, an anti-nausea medication commonly used in military and veteran healthcare settings, represents one of the diverse pharmaceutical commodities delivered through this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/13/26 |